Evidence map›Paper›PMID 38669184›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Structural rearrangements in the nucleus localize latent HIV proviruses to a perinucleolar compartment supportive of reactivation.

Fredrick Kizito, Kien Nguyen, Uri Mbonye, Meenakshi Shukla, Benjamin Luttge, Mary Ann Checkley, Anna Agaponova, Konstantin Leskov, Jonathan Karn

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Fredrick KizitoDepartment of Molecular Biology and Microbiology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0003-4023-9983
Kien NguyenDepartment of Molecular Biology and Microbiology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0002-7088-3457
Uri MbonyeDepartment of Molecular Biology and Microbiology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0002-7694-0803
Meenakshi ShuklaDepartment of Molecular Biology and Microbiology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106.
Benjamin LuttgeDepartment of Molecular Biology and Microbiology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0002-1296-8014
Mary Ann CheckleyDepartment of Molecular Biology and Microbiology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0001-6931-4057
Anna AgaponovaDepartment of Molecular Biology and Microbiology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0003-2248-5523
Konstantin LeskovDepartment of Molecular Biology and Microbiology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0001-6201-5660
Jonathan KarnDepartment of Molecular Biology and Microbiology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0002-2900-094X
Case Western Reserve University · US

Funding

WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Immaculate Lillian Nankya · 1994 to 2026
$50.0M
CRISPR for CureUM1AI164568 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI Tricia Helen Burdo, Kamel Khalili · 2021 to 2026
$27.7M
Microbiology and Immunology Training for HIV and HIV-Related Research in Uganda (MITHU)D43TW010319 · FIC · CASE WESTERN RESERVE UNIVERSITY · PI BOOM, W. HENRY, JOLOBA, MOSES LUTAAKOME · 2016 to 2025
$3.1M
The role of RNA m6A modification in the regulation of HIV latency and reactivationR61AI169629 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KARN, JONATHAN · 2022 to 2024
$2.1M
Control of P-TEFb biogenesis and HIV transcription in primary T-cellsR01AI148083 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KARN, JONATHAN, MBONYE, URI · 2019 to 2023
$2.0M
FIC NIH HHS D43 TW010319NIAID NIH HHS P30 AI036219NIAID NIH HHS R01 AI148083NIAID NIH HHS R61 AI169629NIAID NIH HHS UM1 AI164568
6 · The paper itself

Abstract

Using an immunofluorescence assay based on CRISPR-dCas9-gRNA complexes that selectively bind to the HIV LTR (HIV Cas-FISH), we traced changes in HIV DNA localization in primary effector T cells from early infection until the cells become quiescent as they transition to memory cells. Unintegrated HIV DNA colocalized with CPSF6 and HIV capsid (CA, p24) was found in the cytoplasm and nuclear periphery at days 1 and 3 post infection. From days 3 to 7, most HIV DNA was distributed primarily in the nuclear intermediate euchromatic compartment and was transcribed. By day 21, the cells had entered quiescence, and HIV DNA accumulated in the perinucleolar compartment (PNC). The localization of proviruses to the PNC was blocked by integrase inhibitor Raltegravir, suggesting it was due to chromosomal rearrangements. During the reactivation of latently infected cells through the T cell receptor (TCR), nascent viral mRNA transcripts associated with HIV DNA in the PNC were detected. The viral trans-activator Tat and its regulatory partners, P-TEFb and 7SK snRNA, assembled in large interchromatin granule clusters near the provirus within 2 h of TCR activation. As T cell activation progressed, the HIV DNA shifted away from the PNC. HIV DNA in latently infected memory T cells from patients also accumulated in the PNC and showed identical patterns of nuclear rearrangements after cellular reactivation. Thus, in contrast to transformed cells where proviruses are found primarily at the nuclear periphery, in primary memory T cells, the nuclear architecture undergoes rearrangements that shape the transcriptional silencing and reactivation of proviral HIV.

Indexed as

Cell NucleusHIV-1HIV InfectionsProvirusesVirus ActivationVirus LatencyDNA, ViralHIV Long Terminal RepeatHumansDNA, Viralepigenetic silencingHIV latencyHIV Tatproviral reactivationP-TEFb

Identifiers

PMID38669184
PMCPMC11067448
OpenAlexW4395676720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.